ConsiGma®
ConsiGma® Tablet Coating (TC) Modules
The ConsiGma® TC modules are based on the GEA high-performance tablet coating technology that gently and accurately deposits controlled amounts of coating materials onto tablet cores — even if they are hygroscopic or friable.
ConsiGma-coater
Highly agile and available in 4 standard set-ups, the ConsiGma® TC can coat any amount of tablets between 1.5 kg and 500 kg within a 8 hour shift (up to 1000 kg for a twin-coater system). Nominalthroughputs (from 15 kg/h up to 60 kg/h, to be verified by testing) are flexible due to the interchangeable coating wheels, and the systems can be customized with a number of options to suit the customer’s needs.
They are suitable for applying aesthetic, enteric or API coating in a very accurate way and are ideal for pharmaceutical companies who wish to benefit from a higher process control and resulting higher quality of the product.
The Conductor 4.0 software ensures seamless control of the entire process, full reporting and tracking of OOS. Material genealogy can be integrated into the controls. Handshaking with up- or downstream equipment can also be offered.
Standard Configuration
1 or 2 coater wheels
2 sizes of wheel available
Available options
- Feeding from:
- Fully integrated ConsiGma® CM line
- Standalone tablet press
- Fully integrated with new GEA press
- Handshake with existing or customer selected press
- IBC
- Manual
- Solvent capable
- Wash offline
- PAT Probe
Main benefits
- Ideal conditions for excellent coating quality
- Unique coating concept reducing the risk for common defects
- No risk to lose an entire batch of tablets
- Less coating solution required for effective functional coatings (up to 50% reduction)
- Small footprint relative to the throughput
- No Scale up: same system for R&D, clinical and full scale commercial production
- Can be integrated with various tablet presses for both batch and continuous modes
Read more about how GEA and its partners are implementing this technology to lead the way toward smaller, more flexible, continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.
Downloads
Aanverwante producten
ConsiGma® Direct Compression with Linear Blending (DC-LB) Lines
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
ConsiGma® Granulation and Compression (GC) Lines
Highly integrated solutions for continuous wet granulation, drying and tablet compression, the ConsiGma® GC lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled granulation and improved quality.
ConsiGma® R&D Granulation and Drying (GD)
The ConsiGma® GD 25/80 offers standalone continuous twin-screw granulation and drying for small-scale R&D operations. It allows users to develop the process and achieve high granule quality on a compact unit.
Lighthouse Probe® - online measurement
The Lighthouse Probe® can be used for real-time monitoring of chemical and pharmaceutical processes and provides in-process window cleaning at any time, recalibration during the process, full CIP (cleaning) of wash housing and seal, and a clear view inside – even in difficult conditions.
Gerelateerde video's
ConsiGma Coater - real-time video of coating cycle
GEA-inzichten
In for the better: Community engagement at GEA
To support community engagement, GEA offers employees one day of paid time off per year.
How a digital rotary parlor supports sustainable dairy farming
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
A strategy for the better: CEO interview on GEA's Mission 30
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.
